Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 1.22 is 83% below its 5-year average of 7.28, near the low end of its 5-year range (1.22–16.47).
As of the fiscal period ended Tuesday, June 30, 2026. 42.49% below its 12-month average of 2.11.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 1.22.
CURRENT RATIO
1.22
CURRENT RATIO AVG TTM
2.11
CURRENT RATIO AVG 3Y
4.72
CURRENT RATIO AVG 5Y
7.28
CURRENT RATIO AVG 10Y
N/A
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-42.49%
CURRENT VS 3Y AVG
-74.28%
CURRENT VS 5Y AVG
-83.30%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.76
median of 873 covered companies
CURRENT VS SECTOR MEDIAN
-67.68%
vs the sector median at left
Market Cap
$13.20M
Current Ratio
0.84
TTM Avg
0.51
3Y Avg
4.20
5Y Avg
6.42
Market Cap
$12.78M
Current Ratio
10.57
TTM Avg
6.64
3Y Avg
7.08
5Y Avg
4.73
Market Cap
$12.58M
Current Ratio
0.38
TTM Avg
2.35
3Y Avg
3.38
5Y Avg
3.85
Market Cap
$12.44M
Current Ratio
0.66
TTM Avg
2.17
3Y Avg
2.40
5Y Avg
3.73
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Passage Bio, Inc. (PASG) | $13.11M | 1.22 | 2.11 | 4.72 | 7.28 |
| Citius Pharmaceuticals, Inc. (CTXR)vs › | $13.20M | 0.84 | 0.51 | 4.20 | 6.42 |
| Optimi Health Corp. (OPTH)vs › | $13.30M | 1.73 | 0.30 | 1.36 | 3.00 |
| IN8bio, Inc. (INAB)vs › | $13.33M | 8.21 | 6.45 | 5.32 | 7.60 |
| Bullfrog AI Holdings, Inc. Common Stock (BFRG)vs › | $12.78M | 10.57 | 6.64 | 7.08 | 4.73 |
| Tempest Therapeutics, Inc. (TPST)vs › | $12.58M | 0.38 | 2.35 | 3.38 | 3.85 |
| Dare Bioscience, Inc. (DARE)vs › | $12.48M | 0.99 | 0.99 | 1.05 | 1.43 |
| Obsidian Therapeutics Inc. (OBX)vs › | $13.75M | N/A | N/A | N/A | N/A |
| Cytosorbents Corporation (CTSO)vs › | $12.44M | 0.66 | 2.17 | 2.40 | 3.73 |
| Sintx Technologies, Inc. (SINT)vs › | $13.86M | 2.36 | 1.96 | 1.68 | 3.63 |
Current Ratio
1.22
Quick Ratio
1.22
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 1.22 |
| 2026-03-31 | 1.73 |
| 2025-12-31 | 2.07 |
| 2025-09-30 | 2.51 |
| 2025-06-30 | 3.05 |
| 2025-03-31 | 3.74 |
| 2024-12-31 | 4.07 |
| 2024-09-30 | 5.15 |
| 2024-06-30 | 7.67 |
| 2024-03-31 | 8.43 |
| 2023-12-31 | 7.22 |
| 2023-09-30 | 6.85 |
| 2023-06-30 | 7.73 |
| 2023-03-31 | 9.95 |
| 2022-12-31 | 10.74 |
| 2022-09-30 | 10.29 |
| 2022-06-30 | 9.24 |
| 2022-03-31 | 10.30 |
| 2021-12-31 | 11.02 |
| 2021-09-30 | 16.47 |
| 2021-06-30 | 13.40 |
| 2021-03-31 | 23.16 |
| 2020-12-31 | 14.98 |
| 2020-09-30 | 18.30 |
| 2020-06-30 | 26.05 |
| 2020-03-31 | 73.09 |
| 2019-12-31 | 45.04 |
| 2019-09-30 | 95.28 |
| 2019-06-30 | 0.00 |
| 2019-03-31 | 0.00 |
| 2018-12-31 | 108.79 |
